NCT01093365 - Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

DRUG

Varenicline

"* 0.0 mg orally twice per day for three days (placebo)~* 0.5 mg orally twice per day for three days~* 1.0 mg orally twice per day for three days"

Trial Locations (1)

Centre for Addiction and Mental Health (33 Russell street), Toronto